Home/Filings/4/0001104659-22-084762
4//SEC Filing

Duey Marc 4

Accession 0001104659-22-084762

CIK 0001781983other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 5:00 PM ET

Size

8.3 KB

Accession

0001104659-22-084762

Insider Transaction Report

Form 4
Period: 2022-07-28
Duey Marc
Director
Transactions
  • Award

    Common Stock

    2022-07-28+5,995157,899 total
  • Award

    Stock Option (right to Buy)

    2022-07-28+29,57529,575 total
    Exercise: $1.09Exp: 2032-07-28Common Stock (29,575 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    439
Footnotes (3)
  • [F1]These shares represent restricted stock units which were granted on July 28, 2022, and which will vest and be settled in common stock on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
  • [F2]The option vests in full on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
  • [F3]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, or for any other purpose.

Issuer

Aprea Therapeutics, Inc.

CIK 0001781983

Entity typeother

Related Parties

1
  • filerCIK 0001925150

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:00 PM ET
Size
8.3 KB